Annual Drug Patent Expirations for FINACEA
Finacea is a drug marketed by Leo Pharma As and is included in two NDAs. It is available from three suppliers. There are eight patents protecting this drug and two Paragraph IV challenges.
Drug patent litigation for FINACEA.
This drug has one hundred and thirty-three patent family members in twenty countries.
The generic ingredient in FINACEA is azelaic acid. Three suppliers are listed for this compound. Additional details are available on the azelaic acid profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
